Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall responses to future infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The team from the University of California found that immunization with either Pfizer-BioNTech’s BNT162b2 or Moderna’s mRNA-1273 vaccine-induced enrichment of spike-specific B cells.
The viral spike protein mediates the initial stage of the SARS-CoV-2 infection process and is the primary target of antibodies following natural infection or vaccination.
Ilhem Messaoudi and colleagues say that vaccination also activated CD4 T cells and induced robust antigen-specific polyfunctional CD4 T cell responses.
Furthermore, clonally expanded CD8 T cells were observed in all vaccine recipients.
A pre-print version of the research paper is available on the bioRxiv* server, while the article undergoes peer review.
Vaccination and infection provide two different pathways to immunity
Since the COVID-19 outbreak first began in December 2019 in Wuhan, China, intense global efforts to rapidly develop effective vaccines against the causative agent SARS-CoV-2 have led to the emergency use authorization of several vaccines.
These include the messenger RNA- (mRNA) based vaccines developed by Pfizer (BNT162b2) and Moderna (mRNA-1273). Findings from clinical trials indicated that a 95% maximal protection is achieved within 1 to 2 months following the second dose of either vaccine, including protection against several circulating SARS-CoV-2 variants of concern.
However, the mechanisms by which these vaccines elicit long-lasting cellular immune responses to the virus remain poorly understood.
Natural infection and vaccination provide two different pathways to immunity, which studies have previously shown to be characterized by distinct T and B cell responses.
“Additional studies that integrate functional, transcriptional, and repertoire analysis of the memory immune cell response to COVID-19 mRNA vaccination are needed,” writes Messaoudi and colleagues.
What did the researchers do?
The team used single-cell RNA sequencing and functional assays to assess humoral (antibody) and cellular responses to two doses of either the Pfizer-BioNTech or Moderna mRNA vaccine (14 days following a second dose) in four individuals. The results were compared with the immune responses observed in three convalescent individuals who had experienced asymptomatic or mild infection.
What did the study find?
Both infection and vaccination induced anti-SARS-CoV-2 binding and neutralizing antibodies.
These antibodies were detected as early as two weeks following a first vaccine dose, with levels increasing several-fold after a second dose.
While neutralizing antibody titers following the first vaccine dose were comparable to those among convalescent individuals, significantly higher levels were observed in the vaccinees following the booster dose.
However, several important B cell adaptations were shared between vaccinees and convalescent individuals.
Analysis by flow cytometry revealed a reduction in the level of naïve B cells, but an expansion of memory B cells in both groups.
Additionally, single-cell RNA sequencing showed a reduction in IgA+ memory B cells following vaccination, a finding that has recently been described for convalescent individuals.
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
